Variant · Snv
ELAC2 NM_018127.7(ELAC2):c.155C>G (p.Ser52Cys)
CI-VAR-00044952Explore in graph →p.Ser52CysNM_018127.7:c.155C>GClinVar 241271 rs9895963
Curated evidence
Evidence by cancer (0 items)
Grouped by cancer context first, then therapy. The same variant can be sensitizing in one cancer and irrelevant in another — contexts are never merged. 50 items per page; a cancer group may continue on the next page.
Data not yet available
No curated evidence item references this variant yet.
ClinVar
Clinical significance (1)
ClinVar interpretations are shown as structured records — significance, review status, star rating, conditions — never flattened into one word.
clinvarProvenance
- Source
- NCBI ClinVar (variant_summary)
- Dataset
- ClinVar variant_summary
- Version
- 2026-09-24
- Retrieved
- Sep 29, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Evidence
- database
- License
- Public domain (US Government work, NCBI/NLM); acknowledgment requested
- Run
- ING-CLINVAR-20260929-000001
| Variation | Clinical significance | Review status | Stars | Conditions | Origin | Submitters | Last evaluated | Source |
|---|---|---|---|---|---|---|---|---|
| 241271 | Conflicting classifications of pathogenicity | criteria provided, conflicting classifications | 1 | Combined oxidative phosphorylation defect type 17; Prostate cancer, hereditary, 2; ELAC2-related disorder; Inborn genetic diseases | germline | 8 | Feb 02, 2026 | clinvar |